MARK Anticuerpos
| Empty Table Header | Nombre del producto | CATALOG # | Isotipo | Epítopo | Aplicaciones | Species | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|---|---|
MARK2 Anticuerpo (B-1) | sc-365405 | mouse IgG1 κ | 416-501 (h) | WB, IP, IF, ELISA | h | 2 | ||
MARK3 Anticuerpo (F-6) | sc-376116 | mouse IgG1 κ | 447-501 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
MARK3 Anticuerpo (G-11) | sc-365461 | mouse IgG3 κ | 12-39 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
MARK3 Anticuerpo (G-7) | sc-376115 | mouse IgG2a κ | 447-501 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | new |
MARK CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Nombre del producto | CATALOG # | Species | Aplicaciones | MARCADOR | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|---|
MARK1 Plásmido CRISPR/Cas9 KO (h) | sc-404508 | h | Gene Knockout | GFP | 0 | ||
MARK1 Plásmido HDR (h) | sc-404508-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
MARK2 Plásmido CRISPR/Cas9 KO (h) | sc-403714 | h | Gene Knockout | GFP | 1 | ||
MARK2 Plásmido HDR (h) | sc-403714-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
Plásmido Doble Nickase (h) MARK2 | sc-403714-NIC | h | Gene Knockout | Puromycin | 1 | ||
Plásmido Doble Nickase (h2) MARK2 | sc-403714-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
MARK3 Plásmido CRISPR/Cas9 KO (h) | sc-406362 | h | Gene Knockout | GFP | 0 |
MARK CRISPR Activation Products
| Empty Table Header | Nombre del producto | CATALOG # | Species | Aplicaciones | MARCADOR | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|---|
Plásmido CRISPR de Activación (h) MARK4 | sc-404386-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 |
MARK siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Nombre del producto | CATALOG # | Species | Aplicaciones | MARCADOR | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|---|
MARK1 ARNip (h) | sc-75749 | h | Gene Silencing | N/A | 0 | ||
MARK1 Plásmido shRNA (h) | sc-75749-SH | h | Gene Silencing | Puromycin | 0 | ||
MARK1 shRNA (h) Partículas Lentivirales | sc-75749-V | h | Gene Silencing | Puromycin | 0 | ||
MARK1 ARNip (m) | sc-75750 | m | Gene Silencing | N/A | 0 | ||
MARK1 Plásmido shRNA (m) | sc-75750-SH | m | Gene Silencing | Puromycin | 0 | ||
MARK1 shRNA (m) Partículas Lentivirales | sc-75750-V | m | Gene Silencing | Puromycin | 0 | ||
MARK2 ARNip (h) | sc-45793 | h | Gene Silencing | N/A | 0 | ||
MARK2 Plásmido shRNA (h) | sc-45793-SH | h | Gene Silencing | Puromycin | 0 | ||
MARK2 shRNA (h) Partículas Lentivirales | sc-45793-V | h | Gene Silencing | Puromycin | 0 | ||
MARK2 ARNip (m) | sc-45794 | m | Gene Silencing | N/A | 0 | ||
MARK2 Plásmido shRNA (m) | sc-45794-SH | m | Gene Silencing | Puromycin | 0 | ||
MARK2 shRNA (m) Partículas Lentivirales | sc-45794-V | m | Gene Silencing | Puromycin | 0 | ||
MARK3 ARNip (h) | sc-43649 | h | Gene Silencing | N/A | 0 | ||
MARK3 Plásmido shRNA (h) | sc-43649-SH | h | Gene Silencing | Puromycin | 0 | ||
MARK3 shRNA (h) Partículas Lentivirales | sc-43649-V | h | Gene Silencing | Puromycin | 0 | ||
MARK3 ARNip (m) | sc-60087 | m | Gene Silencing | N/A | 0 | ||
MARK3 Plásmido shRNA (m) | sc-60087-SH | m | Gene Silencing | Puromycin | 0 | ||
MARK3 shRNA (m) Partículas Lentivirales | sc-60087-V | m | Gene Silencing | Puromycin | 0 | ||
MARK4 ARNip (h) | sc-97671 | h | Gene Silencing | N/A | 0 | ||
MARK4 Plásmido shRNA (h) | sc-97671-SH | h | Gene Silencing | Puromycin | 0 | ||
MARK4 shRNA (h) Partículas Lentivirales | sc-97671-V | h | Gene Silencing | Puromycin | 0 | ||
MARK4 ARNip (m) | sc-149275 | m | Gene Silencing | N/A | 0 | ||
MARK4 Plásmido shRNA (m) | sc-149275-SH | m | Gene Silencing | Puromycin | 0 | ||
MARK4 shRNA (m) Partículas Lentivirales | sc-149275-V | m | Gene Silencing | Puromycin | 0 |